COMMUNIQUÉS West-GlobeNewswire

Sangamo Therapeutics Announces Transition to Trading on OTCQB Venture Market
29/04/2026
Sangamo’s common stock to transition trading from The Nasdaq Capital Market to OTCQB Venture Market beginning May 5, 2026 RICHMOND, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a [...]
Ultragenyx to Host Conference Call for First Quarter 2026 Financial Results and Corporate Update
29/04/2026
NOVATO, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra [...]
Doheny Eye Institute Researchers to Share Cutting-Edge Vision Science Across More Than 20 Sessions at the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting
29/04/2026
Doheny scientists, clinician-scientists, and research fellows will present findings on eye disease, advanced imaging, artificial intelligence and more at the preeminent global vision research conference PASADENA, Calif [...]
Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6
29/04/2026
DALLAS, April 29, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene [...]
electroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026
29/04/2026
ROCKAWAY, N.J., April 29, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the first [...]
Ocugen to Host Conference Call on Tuesday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2026 Financial Results
29/04/2026
MALVERN, Pa., April 29, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a [...]
Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation
29/04/2026
THE WOODLANDS, TX, April 29, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today [...]
Ontario Building Code Review Points to a Clear Win for Families and Future Homeowners: Prevent Lung Cancer Cases by Keeping Radon Mitigation Measures in Place
29/04/2026
Lung Health Foundation says existing protections are simple, effective safeguards worth preserving TORONTO, April 29, 2026 (GLOBE NEWSWIRE) -- As Ontario moves to speed up housing construction by cutting red tape, Lung [...]
Imviva Biotech to Present Clinical Data from Ongoing Phase 1/2 Study of CTA313 at the American Society of Gene & Cell Therapy's Annual Meeting
29/04/2026
Dual-targeted allogeneic CAR-T therapy demonstrates immune-reset mechanism and durable remission in system lupus erythematosus BOSTON, April 29, 2026 (GLOBE NEWSWIRE) -- Imviva Biotech, a clinical-stage biotechnology [...]
Agios Reports First Quarter 2026 Financial Results and Provides Business Update
29/04/2026
Mitapivat (PYRUKYND ® and AQVESME™) generated worldwide net revenues of $20.7 million in the first quarter of 2026, compared to $8.7 million in the first quarter of 2025 Strong initial U.S. commercial launch of AQVESME [...]
Boehringer Ingelheim and Eko Health Inc. launch new AI-based solution that detects heart murmurs in dogs
29/04/2026
Eko Vet+ TM | CANINEBEAT ® AI helps veterinarians detect, visualize, and grade heart murmurs in dogs that can otherwise go undetected The CANINEBEAT ® AI algorithm detects heart murmurs associated with structural heart [...]
HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
29/04/2026
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., April 29, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that the New Drug Application (“NDA”) for sovleplenib [...]
Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference
29/04/2026
KIRKLAND, Wash., April 29, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, is scheduled to present at the BofA Securities 2026 [...]
Yinuo Chen, fondateur de trois grands centres de procréation assistée – Tulip, ONELIFE et Sino – a été invité à participer à la Shanghai Medical Exhibition
29/04/2026
BICHKEK, Kirghizistan, 29 avr. 2026 (GLOBE NEWSWIRE) -- Yinuo Chen, fondateur de trois grands centres de procréation assistée – Tulip (Kirghizistan), ONELIFE (Thaïlande) et Sino (Géorgie) – a été invité à participer à l [...]
Regeneron Reports First Quarter 2026 Financial and Operating Results
29/04/2026
First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025 Dupixent ® global net sales (recorded by Sanofi) increased 33% to $4.9 billion EYLEA HD ® U.S. net sales increased 52% to $468 million [...]
Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy
29/04/2026
Ecopipam, Emalex’s investigational asset for pediatric Tourette syndrome (TS), is a first-in-class selective dopamine D1 receptor antagonist with FDA Orphan Drug and Fast Track designations. The late-stage program in a [...]
Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness of NARCAN® Nasal Spray Among Canadians and Help Save Lives
29/04/2026
Star left fielder joins forces with Emergent to educate the public on the importance of being prepared with NARCAN ® Nasal Spray Schneider shares his family’s story as part of Emergent’s Opioid Crisis Impact Map [...]
Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model
29/04/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 29, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel [...]
Enlitic Announces Full Integration with Sectra, Expanding Access for Sectra Customers
29/04/2026
LOVELAND, Colo., April 29, 2026 (GLOBE NEWSWIRE) -- Enlitic today announced the completion of its integration with Sectra, enabling Enlitic to support Sectra customers directly with its Ensight platform. The integration [...]

Pages